Transplant Complication
16
5
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (16)
Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients
Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)
Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Critical Illness After Hematopoietic Cell Transplantation
The Effect of Mandala Therapy on Anxiety and Comfort in Kidney Transplant Recipients
"A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network"
Plant-based Diet for Kidney Transplant Recipients
NEgative prEssure Wound Therapy in Renal Transplant
GEnomic Medicine in Kidney Transplantation Study
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
Comparison of Clinical Value in the Use of the Fascia Lata and Temporal Muscle Fascia in the Reconstruction of the Dura in the Sellar Region
Spatial Transcriptomics in Kidney Transplantation
The Transplant Cohort of the German Center for Infection Research
Enhanced Recovery After Surgery for SPK Transplantation Recipients